Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Collaborates with Sunway Biotech to Launch Global Nutraceuticals Offering
Bora acquires six US brand product licenses, rights
Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing
Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023
Bora Pharmaceuticals Featured in Contract Pharma – “What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?”
Bora Pharmaceuticals Featured in Biopharma Reporter – How Bora Pharmaceuticals is moving into biologics and North America
How Bora Pharmaceuticals is moving into biologics and attempting to crack North America